BioNexus Gene Lab Corp Ordinary Shares BGLC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
-
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
-
BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions
-
BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production
-
BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd
-
BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd
Trading Information
- Previous Close Price
- $0.43
- Day Range
- $0.40–0.45
- 52-Week Range
- $0.31–3.39
- Bid/Ask
- $0.42 / $0.44
- Market Cap
- $7.58 Mil
- Volume/Avg
- 25,304 / 386,568
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.80
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Stock Style Box
- Small Value
- Total Number of Employees
- 30
- Website
- https://www.bionexusgenelab.com
Valuation
|
Metric
|
BGLC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.78 |
Price/Sales | 0.80 |
Price/Cash Flow | — |
Price/Earnings
BGLC
Financial Strength
|
Metric
|
BGLC
|
|---|---|
Quick Ratio | 4.87 |
Current Ratio | 5.60 |
Interest Coverage | −118.90 |
Quick Ratio
BGLC
Profitability
|
Metric
|
BGLC
|
|---|---|
Return on Assets (Normalized) | −22.54% |
Return on Equity (Normalized) | −27.07% |
Return on Invested Capital (Normalized) | −26.50% |
Return on Assets
BGLC
Specialty Chemicals Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Linde PLC
LIN
| Nfsvfbv | Stg | $223.6 Bil | |||
| Sherwin-Williams Co
SHW
| Skjnlktbtt | Mmjp | $93.7 Bil | |||
| Ecolab Inc
ECL
| Dskbrrljx | Dyhz | $71.4 Bil | |||
| Air Products & Chemicals Inc
APD
| Ztpvfyrpvf | Yjgym | $63.5 Bil | |||
| DuPont de Nemours Inc
DD
| Mtyplpd | Qtqflh | $36.5 Bil | |||
| LyondellBasell Industries NV Class A
LYB
| Mtvznjwgm | Qfjlkwk | $31.5 Bil | |||
| PPG Industries Inc
PPG
| Lfyspmcw | Hthxss | $30.0 Bil | |||
| International Flavors & Fragrances Inc
IFF
| Ndplbvszs | Dtj | $25.7 Bil | |||
| Eastman Chemical Co
EMN
| Xdzssdyd | Rbtxxd | $12.7 Bil | |||
| Albemarle Corp
ALB
| Nvlstpsh | Svkdc | $12.0 Bil |
United States